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CORRECTION OF BATCH EFFECTS IN SINGLE CELL RNA SEQUENCING 
DATA USING COMBAT-SEQ  
JONATHAN TYLER DULLEA 
ABSTRACT 
Single cell RNA sequencing allows expression profiles for individual cells to be obtained 
thus offering unprecedented insight into the behavior of individual cells. Insight gained 
from exploration of individual cells has implications in both cancer and developmental 
biology. Much of the power of these models is derived from the shear amount and 
granularity of the data that can be collected; however, with this power comes the 
deleterious introduction of batch effects. Samples sequenced on different days, by 
different technicians can show variance that cannot be attributed to biological condition, 
but rather is only due to the batch in which it was sequenced. These batch effects can 
cause alterations to the perceived relationships between the main effect and the outcome 
of interest, for instance cancer status, the main effect of cancer status may be hidden by 
the unwanted and unmodeled variance. Two known methods for the correction of batch 
effects in bulk RNA sequencing data are ComBat-Seq and Surrogate Variable Analysis; 
in this work, we demonstrate that when cell-type is known, inclusion of that covariate in 
the ComBat-Seq results in an appropriate correction of the batch effect. We also 
demonstrate that when cell-type is not known, SVA can be used to infer cell-type 
information form the latent structure of the count matrix with some loss of accuracy 
compared to the correction with cell type. This cell type information can be used in place 
of the actual cell-type covariate information to correct single cell RNA sequencing data 
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with ComBat-Seq; inclusion of surrogate variables helps the accuracy of the correction in 
certain scenarios. Additionally, in the case where cell-type is not known, and the cell 
proportions are balanced between batches we demonstrate that ComBat-Seq can be used 
naive to cell-type information. The efficacy of this procedure is demonstrated with two 
simulated datasets and a dataset containing Jurkat and t293 cells. These results are then 
compared to Harmony, a recently reported batch correction algorithm. The procedure, 
herein reported, has benefits over harmony in certain situations such as when a counts 
matrix is needed for further analysis or when there is thought to be substantial intra-cell-
type variability across different batches.   
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Introduction to Single Cell RNA Sequencing  
The ability of single cell RNA sequencing to obtain expression profiles of 
individual cells can prove to be exceedingly valuable in many areas of biology. Granular 
information on gene expression in individual cells is particularly useful in the context of 
cancer where sub-clonal mutations can drive both the evolution of tumors and the 
resistance to therapy. Single cell RNA sequencing also has utility in developmental 
biology where it can assess the changes in expression as cell lines (Shalek & Benson, 
2017). In Bulk RNA sequencing, a technology still in wide use and which preceded 
single cell RNA sequencing, bulk samples are sequenced giving an overview of the 
expression profile of the sampled tissue; in bulk RNA sequencing, granular cellular level, 
detail is not retained but rather the average expression across all cells in the tissue is 
given.  
In the context of cancer, the ability to retain granular data on the expression of the 
smallest sub-populations of samples, namely individual cells, could lead to identification 
of a specific therapeutic, or combination thereof, to which the tumor is particularly 
susceptible (Shalek & Benson, 2017). A deeper understanding of the sub-clones present 
in a tissue sample would allow the tailoring of clinical management of disease (Shalek & 
Benson, 2017). Proper selection of therapeutic agent leads to both an increase in efficacy 
of treatment, as a targeted therapeutic could be selected, but also a reduction in cost as 
inappropriate or ineffective treatments could be avoided. Single cell RNA sequencing 
could help select proper therapeutics, for cancer, based on the mutations present in the 
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sub-clonal populations of the sampled tissue (Ren et al., 2018). Furthermore, scRNA-seq 
could help provide insight into the development and natural history of cancer; this could 
have implications in the development of models for metastasis (Ren et al., 2018). 
Data Types and Visualization 
Data Type 
 In single cell RNA sequencing, the individual expression profiles of cells are 
measured.  The number of a specific transcripts in each cell for given genes are 
quantified; a matrix of the counts of the genes is termed the counts matrix. There are 
often thousands of genes that are expressed in each cell. Differences in expression from 
cell to cell drive the structure and function of said cell; these differences in cellular 
expression can be used to characterize the cell type and biological condition such as 
cellular response to stress or metastatic transformation (Hwang et al., 2018). The log 
transformation of this matrix is termed the log-counts matrix; this is often used in 
analysis as the log-counts tend to follow a more normal distribution (Luecken & Theis, 
2019).  
Dimensionality Reduction 
 Single cell RNA sequencing data is highly dimensional; there are often thousands 
of genes and thousands of samples. A common workflow is to normalize this data then 
perform a principal component reduction on this data to parse out the underlying latent 
structure of the matrix. This underlying latent structure can provide information about 
both the cell types and the biological condition of each cell. Each data-point (in this case 
each cell) is assigned a score for each principal component; this score is a measure of the 
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degree to which that cells expression has the character of the principal component. The 
scores of the first and second principal component are often plotted against each other 
(Luecken & Theis, 2019). Groupings of the scores in this two-dimensional reduction give 
some indication of how similar samples are to each other. Two other dimensional 
reduction technique are Uniform Manifold Approximation and Projection (UMAP) and t-
Distributed Stochastic Neighbor Embedding (t-SNE) (Becht et al., 2018; Linderman et 
al., 2019). These are non-linear methods which provide a better separation of groups than 
the linear PCA analysis; the interpretation of the plots of these is similar to that of the 
principal components with the exception that distance between points is not an absolute 
measure of their similarity as would be the case in a PCA plot. 
Figure 1: Example Dimensional Reduction of Single Cell RNA Sequencing Data 
 
 An additional method for visualization of the highly multidimensional data is to 
first perform principal component analysis then second use these principal components as 
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inputs to a non-linear dimensional reduction algorithm such as UMAP or t-SNE. The 
interpretation of this plot is the same as that of a direct dimensional reduction of log 
counts data; however, there are computational advantages of performing it this way given 
the computationally expensive nature of performing a non-linear dimensional reduction 
on a large counts matrix. In this method, the non-linear method is run on a much smaller 
set of data; rather than taking into account every gene, it takes into account only the 
important variation as determined by the first small number of principal components (van 
der Maaten & Hinton, 2008). 
Introduction to Batch Effects 
To take advantage of the power of single-cell RNA sequencing data, large multi-
patient, multi-timepoint datasets, necessary for both models with sufficient power and 
diversity of condition, often must be formed by combination of sequencing runs.  
Samples sequenced on different days, by different labs and by different technicians can 
show variance that cannot be attributed to biological condition but rather due to the batch. 
The non-biological variability is termed a batch effect (Leek, 2014). A batch effect is 
shown in the hypothetical example in Figure 2. Panels A and B both show UMAP 
dimensional reductions of the log-counts of single cell expression data. Panel A 
demonstrates a dataset with a batch effect present. Panel B demonstrates a dataset without 
a visually detectable batch effect in the dimensional reduction. The non-mixing of the 
cells of the same type across batch in panel A is not present in panel B indicating that 




Figure 2: Visualization of Batch Effect. On the left there is a clear batch effect present, 
on the right there is less of a batch effect visualized.  
a b  
If a batch effect alters the perceived expression of a set of genes in a way opposite 
of the effect of interest, for instance cancer status, the main effect of cancer status may be 
hidden by the unwanted and unmodeled variance (Leek, 2014). Currently, experimental 
procedures and appropriate study design are used to mitigate batch effect in scRNA-seq 
data (Tung et al., 2017). One such experimental procedure is to add spike-ins; these are 
known controls to which expression can be normalized after amplification. Additionally, 
one can add unique molecular identifiers, which are not amplified, to further quantify 
technical variation (Tung et al., 2017). In addition to the experimental design, there are 
several batch correction algorithms currently in use that all have advantages and 
disadvantages. There exists a need for development of new statistical procedures to 
account for and model batch effect to bias from downstream analysis. The procedure, 
herein reported, is based on the ComBat-Seq correction algorithm first developed for 
bulk RNA sequencing data (Zhang et al., 2020). 
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Introduction to Batch Correction Algorithms Currently Used in scRNA-SEQ 
Analysis 
Currently, there are several batch correction methods employed for the correction 
of batch effects in single cell RNA sequencing data (Tran et al., 2020). One of the most 
common methods for correction is Harmony. Harmony starts with a low dimensional 
representation of the measured cellular expression profile; namely, this algorithm uses a 
principal component reduction of the data. The low dimensional representation is then 
clustered using a non-discrete clustering algorithm. The cluster assignment is then used to 
determine the centroids of said clusters; this centroid then the used to correct the data in 
that cluster towards the appropriate cluster centroid weighted by membership to that 
cluster. This is done in an iterative manner until convergence is reached (Korsunsky et 
al., 2019). 
The main downside of Harmony correction is that it does not adjust the individual 
expression of genes, thus a counts matrix is not reconstructed in current implementations. 
If one needs a batch adjusted counts matrix, Harmony is not the appropriate algorithm. 
 
Discussion of Balanced and Unbalanced Designs 
A balanced design is one in which the proportion of cells of a given cell type are 
consistent across batches; an unbalanced design is one in which there is not a consistent 
distribution of cells across the different batches (Tung et al., 2017). Experimentally, the 
etiology of an unbalanced design could be either a result of underlying biology or 
sampling procedures. In certain disease states, one cell type could be over-represented; 
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this disease state could be over-represented in a batch resulting in differential distribution 
of cell type across batch. Another cause for differential cell type distribution could be 
sampling differences across the batches. If samples are from a solid tissue biopsy, there 
could be differences in bulk tissue sampled. For instance, in a study examining 
hepatocellular carcinoma one batch could contain samples of hepatic tissue which has 
undergone malignant changes. A second batch could include predominantly normal 
hepatic parenchyma; this would be unbalanced in cell-type across the different tissue 
samples (Tung et al., 2017). 
The balance of cells across batches has implications for batch correction 
algorithms. Certain batch correction algorithms, such as ComBat-Seq do not work well 
with unbalanced designs if information about the covariate which is differentially 
distributed across the batches – in this case cell type –  is not known; the inability of 
ComBat-Seq to correct batch effects in an unbalanced single cell design without 
information about the unbalanced covariate is herein demonstrated. For ComBat-Seq to 
be effective in correction of unwanted variation in single cell RNA sequencing data in 
unbalanced designs, information about the cell type must be known; however as is 
demonstrated in this work, this information must not be explicitly known. 
 
Objectives 
A characteristic inherent to single-cell datasets is that there is intrinsic variance 
not due to batch or biological condition; this variance arises from the fact that individual 
cell types will have unique expression profiles. One cannot in general know the cell type 
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based on expression; if this were the case, cell type could be used as a covariate in the 
ComBat-Seq model. The objective of this manuscript is to explore the ability of ComBat-
Seq to correct batch effects in single cell RNA sequencing data in a few different 
scenarios. Balanced versus unbalanced designs will be examined. Additionally, the case 
where cell type is not known a priori is explored. In the case where cell-type is known, 
that is used as a covariate in the correction. In the unbalanced case where cell-type is not 
known, this work proposes the construction of surrogate variables not to explain batch as 
is typical, but rather to explain cell type. This will be done be modeling batch and disease 
state in the first step of the SVA algorithm; this leaves variance attributed to cell type in 
the residual matrix from which the surrogate variables are constructed. Subsequently, 
these cell type explaining surrogate variables can be included as covariates in the 
ComBat-Seq batch correction model thus accounting for cell type in the adjustment. The 
overall objective of this work is the development of a batch procedure for single cell 




Single Cell RNA Sequencing Data Simulation and Collection 
 
The data obtained from a single cell RNA sequencing experiment can be described by 
a counts matrix with genes as the rows and cells along the columns. Each cell also has 
associated metadata containing information such as the batch and cell type (Luecken & 
Theis, 2019). In this analysis both simulated count data and real count data are used to 
assess the ability of the Single Cell ComBat-Seq procedure to correct batch effects. The 
package SingleCellTK was used to process the data and to create dimensional reduction 
visualizations (Jenkins et al., 2018).  
Simulation of Data 
To characterize the ability of the Single Cell ComBat-Seq to correct batch effects, 
simulated populations of cells were created in-order to have a ground truth to which 
results could be compared. The simulation was done using the software package 
SPARSim (Baruzzo et al., 2020). SPARSim employs a two-step modeling procedure. In 
the first step, the biological variation of the samples is simulated using a gamma model 
parameterized by real datasets. The second step is to model the technical variability. This 
is done using a multivariate hypergeometric distribution which is parameterized by both 
the library size and modeled gene expression for a given gene. The characteristics of the 
datasets generated were based on the Chu preset parameters provided in the SPARSim 
package (Baruzzo et al., 2020). This simulates data to reflect the characteristics of human 
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induced pluripotent stem cells which were differentiated to endodermal cells. This dataset 
is characterized by roughly 51% sparsity with 4 cell types present. 
Two classes of datasets were generated using this algorithm. The first of these 
datasets was simulated to have a somewhat balanced design across cell types (essentially 
equal proportion of cell types in each batch). The second dataset was generated to 
simulate a more unbalanced design (unequal proportion of cell types of a given type in 
each batch).  
 The effect of the parameters on the degree of batch effect was explored through 
fixing the batch distribution parameters for the first batch and scanning over different 
parameter values for the second batch. Batch simulation parameters were set such that for 
batch one, the raw data was scaled by multiplication by a normal distribution with mean 
and variance of one. The batch specific effect for the second batch was parameterized by 
a gamma distribution. The scale and shape parameters of the gamma distributions were 
established by scanning over different values of each ranging from 2 to 30 each in 
increments of 2. The degree of batch effect was quantified by determining the percent of 
variance explained by the batch and the cell type for a given. This scanning of parameters 
was performed for each dataset type – balanced and unbalanced. For each batch, the 
percent variance of the counts for each gene was computed using the package BatchQC 
(Manimaran et al., 2016). This calculates an ANOVA to model the log-counts as a 
function of batch and cell-type. The median explained variance by batch was computed. 
For each class of datasets (balanced and unbalanced) the datasets with maximal median 
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percent of variance in counts explained by batch were selected for further analysis. This 
ensured that the strongest possible batch effect was present in the data-sets selected.  
 This procedure was performed with both balanced and unbalanced designs to 
generate 2 datasets. The minimum number of genes selected was 1700, bottom 20% were 
removed to produce the final raw datasets on which analysis was performed.  
Real Dataset 
The next dataset examined was the pre-processed and publicly available Jurkat/T-293 
dataset used in the harmony paper (Korsunsky et al., 2019). This processing was 
performed as follows: all cells that contained either less than 500 genes total or cells 
whose RNA content is greater than 20% mitochondrial were excluded. Each cell was then 
library normalized to have 10,000 reads per cell. This was then log-normalized from 
which the 1000 most variable genes were established in each cell. The 1,000 most 
variable genes were pooled across all cells and these genes were used for further analysis. 
Single Cell ComBat-Seq Procedure 
Procedure Overview 
The Single-Cell ComBat-Seq procedure for correction of batch effects in single 
cell RNA-Sequencing data leverages ComBat-Seq for correction and possibly Surrogate 
Variable Analysis for cell type identification (Leek, 2014; Zhang et al., 2020). A general 
overview of the procedure is presented here. A detailed description of each end of the 
decision tree is presented in the next section. There are a series of questions that must be 
answered to select the appropriate algorithm. The first question is: “Are the cell-types 
known (or discoverable)?”. If the answer is yes to this question, then ComBat-Cell-Seq 
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should be used. If the answer to this question is no, then the next question is: “Are the 
cell types expected to be balanced?”. If this question is answered in the affirmative, then 
ComBat-Seq can be used. Otherwise, cell type information should be calculated by 
surrogate variable analysis yielding the ComBat-SVA-Seq algorithm.  
 
Figure 3: ComBat-SC-Seq Algorithm Decision Tree 
 
 
 ComBat-Cell-Seq and ComBat-SVA-Seq are specific applications of the 
previously published ComBat-Seq algorithm with either cell type information of 
surrogate variable information included in the adjustment model to prevent loss of cell 
type information in the correction. The algorithmic details of each constituent part of this 
procedure are presented in the sections below. 
Surrogate Variable Analysis Algorithm 
 Surrogate Variable analysis is a technique that was developed to model laten 
variation in genomic expression studies that is not explicitly known. It was then extended 
to sequencing data. Surrogate variables are commonly used to model the batch effect 
present in a study so that it can be adjusted out of the analysis. In this algorithm, three 
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sources of genetic variation are described. Primary measured variables are explicitly 
modeled by the study; this could include sex, biological condition, or age variation in 
gene expression. The next source of variation is the unmodeled variance. This is variance 
that is not directly attributable to the modeled factors in the analysis. This could be 
variance that is attributed to batch or some other underlying modeled variance not 
captured by the clinical covariates. The last source of variation described is the gene-
specific noise (Leek, 2014). 
 Surrogate variable analysis uses information across all genes to estimate the effect 
of the unmodeled variance on the overall expression data. The algorithm works by first 
modeling the expression as a function of the known covariates (such as age and 
biological condition). Then uses the model to reconstruct a modeled counts matrix. The 
difference between the modeled counts matrix and the empirical counts matrix calculated 
and termed the residual matrix. This matrix is then decomposed using singular value 
decomposition and variables that are statistically not noise are retained. This 
decomposition provides the surrogate variables which are related to the unmodeled 
variance (Leek, 2014). 
 In this application, covariates that explain variance in the data which are cell-type 
are used to build the surrogate variables; this includes batch. The resulting surrogate 
variables thus explain the variance attribute to cell-type without ever explicitly knowing 






The ComBat-Seq algorithm was developed to correct batch effects in bulk RNA 
sequencing data. It works by first modeling the expression using negative binominal 
regression which accounts for the batch and biological condition. Next, the “batch free” 
distributions are calculated which represent what the distribution of counts would be 
provided that there was no batch effect. The empirical data is then adjusted to the “batch-
free” distribution using quantile matching (Zhang et al., 2020). 
Application of these methods to single cell RNA Sequencing data 
 
 First, the case where cell type is known is considered. In this case, the cell type 
covariates are included in the ComBat-Seq correction model to ensure that this variance 
is retained after correction. The next case is where cell-type is not known, but the design 
is thought to be balanced. In this case, a ComBat-Seq correction is performed without any 
covariate information to model the cell type. In this special case where cell type does not 
substantially differ between groups, the ComBat-Seq does not remove variance attributed 
to cell type. In the last case where cell-type is not known and there is belief that the cells 
are not evenly distributed between batches, ComBat-SVA-Seq should be employed. In 
this method, surrogate variables are built to model the cell type. This is done by modeling 
all variance in the data that is not attributed to cell type – this could include covariates 
such as batch or biological condition. The surrogate variables are then included in the 
batch correction; generally, we have found that the number of surrogate variables that 
should be included is the number of unique cell types minus one as this is adequate to 
uniquely define the cell types.  
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Comparison of Methods 
 The first comparison that was performed was the comparison of the different 
ComBat-Seq based correction algorithms; namely ComBat-Seq, ComBat-SVA-Seq, and 
ComBat-SVA-Seq. The results from this algorithm were compared in a couple different 
ways. The first comparison was that using a visual comparison of the concordance 
between the batches before and after correction by the various algorithms. Uniform 
Manifold Approximation and Projection (UMAP) of the log counts was chosen for this 
dimensional reduction. The different ComBat-Seq based corrections were compared to 
each other using an ANOVA framework. For each gene present, the log counts were 
modeled as a function of the batch and cell-type. The total explained variance was 
calculated as well as the component of the variance attributed to batch and that explained 
by cell type. An appropriate batch correction is seen by a reduction in the variance 
explained by the batch variable while retaining variance attributed to cell-type 
The second comparison that was performed was a comparison to Harmony. The 
harmony method does not provide a counts matrix as an output; accordingly, the 
characterization of the percent of variance in counts explained by batch and cell type is 
not possible in the same manner. Instead, the comparison was only performed visually. 
Harmony returns corrected principal components. A UMAP was performed on the 
corrected principal components. To have a fair comparison of the ability of the methods 
to perform the correction the same visualization principal was applied to the ComBat-Seq 
based corrected data. The count data was first corrected with the appropriate variation of 
ComBat-Single-Cell-Seq. The first 20 principal components were calculated, and these 
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were projected with UMAP. The UMAP plots of the Harmony and ComBat-Seq 




There were two sets of analyses performed – that on simulated data and that on 
real single-cell RNA sequencing data. With the simulated datasets, we assessed the 
ability of Single Cell ComBat-Seq to correct the batch effect in both a balanced and 
unbalanced design. Single Cell ComBat-Seq was then used to correct a batch effect 
present in a real dataset. These results are compared to a Harmony batch correction. 
The second set of analyses was performed with the Jurkat/t293 dataset 
demonstrated in the original manuscript describing Harmony. These datasets have 
previously been pre-processed as described in the methods section. We then performed 
the ComBat-SC-Seq based batch correction on these datasets both under and not under 
the assumption of prior knowledge of cell-type.  
Simulated Data Analysis – Balanced Design 
Datasets were generated to include 4 cell types across two different batches. Each batch 
contained 250 cells for a total of 500 cells. There were 10,000 possible genes that were 
expressed in this simulated dataset. The dataset with the greatest possible batch effect 
was chosen as described below. The ComBat-Seq based batch correction algorithms were 
the applied to this dataset. Additionally, the Harmony based batch correction was also 




Selection of Simulation Parameters 
To select the simulation parameters that would be used to generate the batches, a 
series of balanced single cell RNA sequencing datasets were simulated. The percent of 
variance in log-counts that is explained by batch was computed as explained in the 
methods section. The results are summarized in Table 1 below. From this generated data, 
the maximum value of explained variance by batch was selected for further analysis. The 
batch with the largest batch effect was that with simulation parameters of 6 and 2 for the 
shape and scale respectively.  
Table 1: Explained Variance by Batch in Simulated Balanced Design  
Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
2 2 2.3155  12 2 2.2705  22 2 2.1665 
2 4 1.552  12 4 1.615  22 4 1.561 
2 6 1.3545  12 6 1.3495  22 6 1.3255 
2 8 1.338  12 8 1.2775  22 8 1.285 
2 10 1.1385  12 10 1.158  22 10 1.2425 
2 12 1.127  12 12 1.1725  22 12 1.1625 
2 14 1.1085  12 14 1.141  22 14 1.1465 
2 16 1.1755  12 16 1.128  22 16 1.1115 
2 18 1.0345  12 18 1.04  22 18 1.0515 
2 20 1.074  12 20 1.0835  22 20 1.033 
2 22 0.9855  12 22 1.06  22 22 0.989 
2 24 1.026  12 24 1.044  22 24 0.975 
2 26 1.0255  12 26 1.018  22 26 1.006 
2 28 1.0325  12 28 1.0445  22 28 0.987 
2 30 1.0265  12 30 1.02  22 30 0.986 
4 2 2.234  14 2 2.135  24 2 2.048 
4 4 1.6905  14 4 1.5945  24 4 1.603 
4 6 1.422  14 6 1.388  24 6 1.4045 
4 8 1.324  14 8 1.2575  24 8 1.3275 
4 10 1.254  14 10 1.1395  24 10 1.2135 
4 12 1.161  14 12 1.1115  24 12 1.146 
4 14 1.15  14 14 1.0535  24 14 1.0595 
4 16 1.123  14 16 1.0255  24 16 1.0395 
4 18 1.005  14 18 1.068  24 18 1.0865 
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Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
4 20 1.029  14 20 1.0785  24 20 1.0155 
4 22 1.038  14 22 1.0785  24 22 1.057 
4 24 0.9975  14 24 0.976  24 24 1.03 
4 26 1.018  14 26 1.022  24 26 1.049 
4 28 1.015  14 28 1.0025  24 28 1.059 
4 30 1.0305  14 30 1.087  24 30 0.9945 
6 2 2.3805  16 2 2.1715  26 2 2.2235 
6 4 1.5155  16 4 1.5775  26 4 1.5485 
6 6 1.414  16 6 1.377  26 6 1.334 
6 8 1.319  16 8 1.2225  26 8 1.2455 
6 10 1.2115  16 10 1.174  26 10 1.149 
6 12 1.11  16 12 1.183  26 12 1.1395 
6 14 1.0755  16 14 1.089  26 14 1.092 
6 16 1.127  16 16 1.0785  26 16 1.054 
6 18 1.075  16 18 1.0795  26 18 1.0685 
6 20 0.998  16 20 1.0165  26 20 1.086 
6 22 1.065  16 22 1.0675  26 22 1.042 
6 24 1.027  16 24 0.9805  26 24 1.083 
6 26 1.022  16 26 1.0535  26 26 1.094 
6 28 1.0705  16 28 1.0435  26 28 1.0145 
6 30 1.007  16 30 0.9925  26 30 1.0295 
8 2 2.103  18 2 2.1885  28 2 2.212 
8 4 1.616  18 4 1.664  28 4 1.548 
8 6 1.35  18 6 1.298  28 6 1.329 
8 8 1.2475  18 8 1.241  28 8 1.1945 
8 10 1.236  18 10 1.164  28 10 1.193 
8 12 1.088  18 12 1.182  28 12 1.118 
8 14 1.094  18 14 1.0485  28 14 1.193 
8 16 1.044  18 16 1.0525  28 16 1.1225 
8 18 1.106  18 18 1.0735  28 18 1.0845 
8 20 1.065  18 20 1.049  28 20 1.048 
8 22 1.079  18 22 1.0875  28 22 1.049 
8 24 1.021  18 24 1.06  28 24 1.0185 
8 26 0.974  18 26 0.9795  28 26 0.964 
8 28 0.9595  18 28 1.048  28 28 1.057 
8 30 0.989  18 30 0.979  28 30 1.0065 
10 2 2.2515  20 2 2.2025  30 2 2.374 
10 4 1.634  20 4 1.525  30 4 1.675 
10 6 1.3025  20 6 1.372  30 6 1.253 
10 8 1.218  20 8 1.2275  30 8 1.2035 
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Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
10 10 1.166  20 10 1.1845  30 10 1.1695 
10 12 1.209  20 12 1.1345  30 12 1.1165 
10 14 1.0875  20 14 1.062  30 14 1.12 
10 16 1.072  20 16 1.099  30 16 1.1205 
10 18 1.018  20 18 1.113  30 18 1.0655 
10 20 1.128  20 20 1.075  30 20 1.037 
10 22 1.0355  20 22 1.0495  30 22 1.1135 
10 24 1.0485  20 24 0.9885  30 24 1.0245 
10 26 1.041  20 26 1.044  30 26 1.018 
10 28 1.052  20 28 1.028  30 28 0.9855 
10 30 1.046  20 30 1.051  30 30 0.989 
 
Balanced Dataset Characteristics 
The simulated dataset, with the maximal batch effect, was generated with 
simulation parameters of 0,1 for the mean and standard deviation of the first batch and 6 
and 2 for the shape and scale of the second batch. A summary of the dataset 
characteristics is shown below in table 2. After filtering out cells with less than 1700 
genes per cell and filtering out the bottom 20% of expression there were a total of 290 











Table 2: Dataset characteristics for balanced simulated dataset 
Metric Batch 1 Batch 2 Overall 
Number of Samples 189 101 290 
Number of Genes 8000 8000 8000 
Average Number of Reads per cell 1273199 1331524 1293512 
Average Number of Genes per cell 5635 5633 5634 
Cell Types    
 Cell Type 1 44 21 65 
 Cell Type 2 43 14 57 
 Cell Type 3 57 35 92 
 Cell Type 4 45 31 76 
 
A UMAP plot of the log counts of the data is shown in figure 4 below. A clear 
batch effect is present in this data as evident by both the non-overlapping of the batches 
within a given cell type. Additionally, components of total variance for each gene 
explained by cell-type and batch are shown in figure 5 below. It can be seen here that a 
reasonable portion of the total variance is explained by batch. It should also be noted that 
the design is somewhat balanced with the greatest discrepancy in cell-type proportion in 
























ComBat-Seq Batch Correction 
 
Frist, the ComBat-Seq algrothim was used with no cell-type covariates included 
in the model. To visualize the ability of this procedure to correct the batch effect present 
was first examined visually by performing a UMAP on the log counts. This plot is shown 
in figure 6 below. This appears to have effectively corrected the batch effect as there is 
appreciable mixing of the batches within each cell type. To further examine the ability of 
this procedure to correct the batch effect, the percent variance in log counts for each gene 
explained by cell-type and batch was calculated; this is shown below in figure 7. Most of 
the variance in gene expression, after correction, is explained by cell type; given that 
there is no other biological condition modeled in this simulated data, this indicates that 
the batch correction is effective.  
 






Figure 7: Simulated Batch Effect Balanced Design Explained Variance by Batch 
after ComBat-Seq correction  
 
ComBat-Cell-Seq Batch Correction 
 
Next, a ComBat-Seq batch correction was performed including cell-type as a covariate in 
the batch correction; this is termed the ComBat-Cell-Seq correction. Again, to examine 
the ability of this procedure to correct the batch effect present in the data, a UMAP plot 
of the log counts was performed. This is show in the figure below. The batch effect 
appears to have been appropriately corrected by ComBat-Cell-Seq as well.  The 
explained variance plot for this correction also demonstrates that almost all the variance 
is explained by cell-type after ComBat-Cell-Seq correction with little of the variance 
explained by batch. Again, this is evidence of an appropriate correction because there 
was no other biological condition modeled in the simulation. Visually, the correction 
does not appear to be visually different after inclusion of the cell-type covariates in this 




Figure 8: Simulated Batch Effect Balanced Design ComBat-Cell-Seq Corrected 
UMAP plot 
 
Figure 9: Simulated Batch Effect Balanced Design Explained Variance by Batch 







ComBat-SVA-Seq Batch Correction 
Using the same simulated data, we then explored the ability of surrogate variable 
analysis to provide cell-type information to be used as a covariate in the ComBat-Seq 
correction method in the event that this information is not readily known. It should be 
noted that given the known balance of this design, this method is, in general, not 
recommended in this case. 
The first step in this procedure is to compute the surrogate variables. These 
surrogate variables were computed to model the cell-type variance. In this case, the only 
other source of variance is batch; as such, SVA was used to compute latent structure of 
the counts matrix which is not related to this unwanted batch variation. The relationship 
between the first 8 surrogate variables and cell type is shown in figure 10 below. There 
are clear differences in the surrogate variables across the cell-types for the first four 
surrogate variable after which point there does not seem to be a substantial difference in 
the median surrogate variable value across cell-type.  
After computation of the surrogate variables, a ComBat-Seq correction was 
performed including the surrogate variables as covariates in the correction. It was known 
a-priori that there are 4 cell-types present in this dataset; accordingly, 3 surrogate 
variables were included as covariates to uniquely explain the variance attributable to cell 
type. This is supported by evidence seen in figure 10 where the first 4 surrogate variables 
seem to be related to cell-type; linear combinations of these variables could conceivably 
define the cell type. 
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As was the case in the ComBat-Seq correction and the ComBat-Cell-Seq 
correction, this method appropriately corrects the batch effect. This is demonstrated in the 
UMAP plot of the log counts below. In this plot, there is little variance in the UMAP 
scores which can be attributed to batch. Additionally, in the explained variance plot, there 
was a drastic reduction in the variance that is explained by batch as was the case in the 
prior two methods.  
Figure 10: Simulated Batch Effect Balanced Design Surrogate Variables 1-4 to 


















Figure 11: Simulated Batch Effect Balanced Design Surrogate Variables 5-8 to 






























Figure 12: Simulated Batch Effect Balanced Design ComBat-SVA-Seq Corrected 
UMAP plot 
 
Figure 13: Simulated Batch Effect Balanced Design Explained Variance by Batch 








Comparison of ComBat-Seq based Corrections 
 
Duplicated below are the UMAP plots of the log counts of both the uncorrected 
and the corrected data. Visually, it appears that all the correction procedures performed 
on this data appropriately remove the unwanted variation related to batch. There is no 
clear advantage to any of the procedures visually; computationally, ComBat-Seq and 
ComBat-Cell-Seq have advantages due to the computational cost of computation of 
surrogate variables.  















Comparison of ComBat-Seq Based Results to Harmony 
 
In addition to the ComBat-Seq based corrected datasets, the data was also 
corrected using Harmony batch correction. First, the principal components of the log 
counts matrix were computed. Next, the Harmony procedure was employed to perform 
the batch correction on the first 20 principal components to yield corrected principal 
components. The corrected principal components were then used to perform a Harmony 
adjustment. A UMAP was performed using these corrected principal components; this is 
shown in the figure below.   
For both the uncorrected data and the ComBat-Seq based method corrected log 
counts matrices, the principal components were also computed. These were used to 
perform the same UMAP dimensional reduction as in the Harmony visualization. These 
are also all summarized in the figure below. Visually, all of the ComBat-Seq based 
procedures seem to correct the data appropriately with no clear advantage of one over the 
other. The correction with the Harmony algorithm does not appear to appropriately 






























Simulated Data Analysis – Unbalanced Design 
After demonstration of the method in the simulated somewhat balanced design, a 
more unbalanced design was explored. The datasets were simulated using the same 
underlying batch parameters; however, the initial proportion of cells simulated in each 
batch was no-longer balanced. Each batch contained 250 cells for a total of 500 cells. 
There were again 10,000 possible genes that were expressed in this simulated dataset.  
Selection of Simulation Parameters 
The same procedure was used to select the simulation parameters that would be 
used to generate the batches. A series of unbalanced single cell RNA sequencing datasets 
were simulated. The percent of variance in log-counts that is explained by batch was 
computed as explained in the methods section. The results are summarized in Table 3 
below. From this generated data, the maximum value of explained variance by batch was 
selected for further analysis. The batch with the largest batch effect was that with 
simulation parameters of 24 and 2 for the shape and scale respectively.  





 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
2 2 2.697  12 2 2.676  22 2 2.79 
2 4 1.9305  12 4 2.1375  22 4 2.1475 
2 6 1.837  12 6 1.817  22 6 1.878 
2 8 1.778  12 8 1.675  22 8 1.7005 
2 10 1.5845  12 10 1.68  22 10 1.619 
2 12 1.53  12 12 1.5485  22 12 1.511 
2 14 1.5035  12 14 1.4785  22 14 1.4945 
2 16 1.512  12 16 1.5465  22 16 1.544 
2 18 1.5635  12 18 1.459  22 18 1.4615 
2 20 1.4315  12 20 1.4735  22 20 1.452 
2 22 1.517  12 22 1.3845  22 22 1.47 







 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
2 26 1.543  12 26 1.453  22 26 1.434 
2 28 1.456  12 28 1.549  22 28 1.4 
2 30 1.4805  12 30 1.429  22 30 1.3815 
4 2 2.6285  14 2 2.6155  24 2 2.844 
4 4 2.0235  14 4 2.0535  24 4 2.115 
4 6 1.718  14 6 1.7225  24 6 1.7975 
4 8 1.6705  14 8 1.5985  24 8 1.6175 
4 10 1.618  14 10 1.5685  24 10 1.693 
4 12 1.4875  14 12 1.536  24 12 1.53 
4 14 1.478  14 14 1.614  24 14 1.531 
4 16 1.528  14 16 1.4365  24 16 1.575 
4 18 1.474  14 18 1.477  24 18 1.537 
4 20 1.406  14 20 1.4295  24 20 1.517 
4 22 1.482  14 22 1.4545  24 22 1.475 
4 24 1.422  14 24 1.426  24 24 1.436 
4 26 1.4815  14 26 1.442  24 26 1.4045 
4 28 1.5095  14 28 1.477  24 28 1.3985 
4 30 1.4445  14 30 1.4365  24 30 1.401 
6 2 2.6675  16 2 2.799  26 2 2.769 
6 4 2.0125  16 4 1.979  26 4 2.158 
6 6 1.869  16 6 1.8255  26 6 1.743 
6 8 1.663  16 8 1.664  26 8 1.723 
6 10 1.6  16 10 1.581  26 10 1.599 
6 12 1.548  16 12 1.517  26 12 1.5315 
6 14 1.437  16 14 1.641  26 14 1.629 
6 16 1.5145  16 16 1.521  26 16 1.4665 
6 18 1.4815  16 18 1.47  26 18 1.455 
6 20 1.523  16 20 1.491  26 20 1.498 
6 22 1.5355  16 22 1.5315  26 22 1.524 
6 24 1.487  16 24 1.432  26 24 1.49 
6 26 1.436  16 26 1.414  26 26 1.5415 
6 28 1.4435  16 28 1.4115  26 28 1.51 
6 30 1.501  16 30 1.422  26 30 1.522 
8 2 2.712  18 2 2.692  28 2 2.6695 
8 4 2.088  18 4 2.0205  28 4 2.1225 
8 6 1.79  18 6 1.8145  28 6 1.8105 
8 8 1.667  18 8 1.676  28 8 1.6725 
8 10 1.623  18 10 1.6155  28 10 1.5355 
8 12 1.563  18 12 1.5465  28 12 1.6715 







 Shape Scale Explained 
Variance 
 Shape Scale Explained 
Variance 
8 16 1.4755  18 16 1.4365  28 16 1.3925 
8 18 1.5525  18 18 1.55  28 18 1.5945 
8 20 1.4815  18 20 1.6335  28 20 1.4015 
8 22 1.471  18 22 1.492  28 22 1.477 
8 24 1.479  18 24 1.459  28 24 1.509 
8 26 1.42  18 26 1.4165  28 26 1.421 
8 28 1.4155  18 28 1.4845  28 28 1.382 
8 30 1.3605  18 30 1.59  28 30 1.4005 
10 2 2.781  20 2 2.7345  30 2 2.702 
10 4 1.988  20 4 2.148  30 4 1.993 
10 6 1.72  20 6 1.824  30 6 1.8495 
10 8 1.7565  20 8 1.662  30 8 1.707 
10 10 1.5925  20 10 1.6275  30 10 1.607 
10 12 1.602  20 12 1.627  30 12 1.525 
10 14 1.5405  20 14 1.5055  30 14 1.519 
10 16 1.4015  20 16 1.537  30 16 1.458 
10 18 1.5075  20 18 1.5595  30 18 1.491 
10 20 1.4345  20 20 1.435  30 20 1.533 
10 22 1.438  20 22 1.4525  30 22 1.5115 
10 24 1.395  20 24 1.497  30 24 1.4745 
10 26 1.4  20 26 1.446  30 26 1.452 
10 28 1.5175  20 28 1.4645  30 28 1.467 
10 30 1.5005  20 30 1.5215  30 30 1.4625 
 
Unbalanced Design  
The simulated dataset, with a small batch effect, was generated with simulation 
parameters of 0,1 for the first mean and standard deviation in batch and 4 and 14 for the 
shape and scale in the second batch. A summary of the dataset characteristics is shown 
below in table 3. After filtering out cells with less than 1700 genes per cell and filtering 
out the bottom 20% of expression there were again a total of 290 cells retained. There is a 




Table 4: Dataset characteristics for balanced simulated dataset 
 
Metric Batch 1 Batch 2 Overall 
Number of Samples 191 99 290 
Number of Genes 8000 8000 8000 
Average Number of reads per cell 1272691 1333486 1293445 
Average Number of Genes per cell 5692 5511 5630 
Cell Types    
 Cell Type 1 44 21 65 
 Cell Type 2 19 38 57 
 Cell Type 3 83 9 92 
 Cell Type 4 45 31 76 
 
A UMAP plot of the log-counts of the data is shown in figure 16 below. A clear batch 
effect is present in this data as evident by both the non-overlapping of the batches within 
a given cell type. There is also unbalance seen in this data, especially in cell-type 3 where 
there are 83 cells present in batch one and 9 present in batch two. Additionally, 
components of total variance for each gene explained by cell-type and batch are shown in 
figure 17 below. It can be seen here that a reasonably large portion of the total variance is 








Figure 16: Simulated Batch Effect Unbalanced Design Uncorrected UMAP plot 
 
 









ComBat-Seq Batch Correction 
ComBat-Seq was again used with no cell-type covariates included in the model. It 
should be noted that given the unbalance of the design, this method is not recommended 
for this dataset; this was included as it was used in development of the procedure. A 
UMAP projection was performed on the log-counts; this is presented in figure 18 below. 
Compared to the uncorrected data, there does seem to be less of a batch effect present in 
this corrected data; however, the data are not completely without batch effect. This is 
especially true in cell-types 1 and 2 where there is little overlap in the batches within a 
given cell-type group. In the explained variance plot, it can be seen that there is very little 
variance left which is attributed to batch. 






Figure 19: Simulated Batch Effect Unbalanced Design Explained Variance by Batch 
after ComBat-Seq correction
 
ComBat-Cell-Seq Batch Correction 
Next, a ComBat-Seq batch correction was performed this time including cell-type 
as a covariate in the batch correction; this is termed the ComBat-Cell-Seq procedure. 
Again, to examine the ability of this procedure to correct the batch effect present in the 
data, a UMAP plot of the log counts was performed. This is show in the figure below. 
The batch effect appears to have been appropriately corrected by ComBat-Cell-Seq. The 
correction appears to be more appropriate than that performed by ComBat-Seq alone. 
This is especially evident in the cell groups that ComBat-Seq had trouble with, namely 
cell type 1 and 2. ComBat-Cell-Seq was able to correct this data to that there is 
appropriate overlap of the datasets in these cell type groupings.  The explained variance 
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plot for this correction also demonstrates that almost all the variance is explained by cell-
type after ComBat-Cell-Seq correction with little of the variance explained by batch. 
 

















Figure 21: Simulated Batch Effect Unbalanced Design Explained Variance by Batch 
after ComBat-Seq correction 
 
 
ComBat-SVA Seq Batch Correction 
We then explored the ability of surrogate variable analysis to provide cell-type 
information to be used as a covariate in the ComBat-Seq correction method in the event 
that this information is not readily known. Given that there is an unbalanced design, this 
is the preferred method in the case that cell-type is not known.  
The first step in this procedure is to compute the surrogate variables. These 
surrogate variables were computed to model the cell-type variance. In this case, the only 
other source of variance is batch; as such, SVA was used to compute latent structure of 
the counts matrix which is not related to this unwanted batch variation. The relationship 
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between the first 8 surrogate variables and cell type is shown in figure 22 below. As was 
the case in the balanced design, it can again be seen that there are clear differences in the 
surrogate variables across the cell-types for the first four surrogate variable after which 
point there does not seem to be a substantial difference in the median surrogate variable 
value across cell-type.  
After computation of the surrogate variables, a ComBat-Seq correction was 
performed including the surrogate variables as covariates in the correction. It was known 
a-priori that there are 4 cell-types present in this dataset; accordingly, 3 surrogate 
variables were included as covariates to uniquely explain the variance attributable to cell 
type. This is supported by evidence seen in figure 22 and 23 where the first 4 surrogate 
variables seem to be related to cell-type; linear combinations of these variables could 
conceivably define the cell type. 
As was the case in the ComBat-Seq correction and the ComBat-Cell-Seq 
correction, this method removes the majority of the variance attributed to cell type. This 
is demonstrated in the UMAP plot of the log counts below. The correction was not as 
effective as that with ComBat-Cell-Seq; however, the correction does appear to be 








Figure 22: Simulated Batch Effect Unbalanced Design Surrogate Variables 1-4 to 






























Figure 23: Simulated Batch Effect Unbalanced Design Surrogate Variables 5-8 to 







































Comparison of ComBat-Seq Based Corrections 
 
Duplicated below are the UMAP plots of the log counts of both the uncorrected 
and the corrected data. It is clear from these plots that the best correction was performed 
with ComBat-Cell-Seq; there is visually little batch effect still present in this data. The 
other ComBat-Seq based correction methods reduced the overall batch effect; however, 
there is still a mild batch effect present in these data.  

















Comparison of ComBat-Seq based Results to Harmony 
 
The last comparison performed with this simulated data was a comparison of the 
ability of the ComBat-Seq based methods to perform the correction compared to the 
Harmony correction. First, the principal components of the log counts matrix were 
computed. Next, the Harmony procedure was employed to perform the batch correction 
on the first 20 principal components to yield corrected principal components. The 
corrected principal components were then used to perform a Harmony adjustment. A 
UMAP was performed using these corrected principal components; this is shown in the 
figure below.   
For both the uncorrected data and the ComBat-Seq based method corrected log 
counts matrices, the principal components were also computed. For the raw log-counts 
matrices and the ComBat-Seq based correction methods, the first 20 principal 
components were computed. These were used to perform the same UMAP dimensional 
reduction as in the Harmony visualization. These are also all summarized in figure 27 
below.  
ComBat-Seq based methods seem to vastly out-perform Harmony in this 
unbalanced design. In ComBat-Seq and ComBat-SVA-Seq, there is a slight visual batch 
effect present, especially in cell-type 1. This batch effect is not present in the ComBat-
Cell-Seq adjusted data. In looking at the Harmony corrected data, there is a clear and 



























Analysis of Real Datasets – Jurkat and t293 cells 
The dataset used in the comparison was one of that which was used in the original 
paper reporting the Harmony Batch Correction method. Datasets were downloaded from 
the source files cited in the original paper. These datasets were pre-processed by the 
processing parameters defined in the harmony batch correction paper. These datasets 
were preprocessed by removing all calls with low expression or were greater than 20% 
mitochondrial RNA (Korsunsky et al., 2019). 
 
Dataset Summary  
There were a total of 9478 cells included in this dataset which were sequenced in 
3 different batches. In one batch, there were only Jurkat cells, in the second batch there 
were only 293T cells, in the last batch there were a mix of both Jurkat and 293T cells. 
The summary of the datasets is below.  
Table 5: Dataset characteristics for Jurkat/t293 dataset 
 
Metric Half Jurkat Only T293 Only Overall 
Number of Samples 3364 3255 2859 9478 
Number of Genes 1526 1526 1526 1526 
Average Number of reads per cell 9815 10589 9977 10130 
Average Number of Genes per cell 864 879 812 854 
Cell Types     
 Jurkat Cells 1799 3255 0 5054 




The data were visualized with the two UMAP plots of the log-counts of the data.  The 
first plot has the data colored by the batch and the second plot has the data colored by the 
cell type. This data has a clear batch effect. The Jurkat cells in the Jurkat only batch and 
the half and half batch separated in UMAP space. There is seemingly good overlap in the 
t293 cells in the t293 only batch and the half and half batch  
 
















Figure 29: UMAP Plot of Raw Log-counts of Data Colored by Cell Type 
 
The explained variance by the cell-type and batch are shown in the figure below. There is 
only slightly more variance in log counts explained by cell-type than batch which is 
indicative of a large batch effect. 




ComBat-Seq Batch Correction 
As was the case with the simulated data, the first batch correction that was 
performed was that with the ComBat-Seq algorithm and no cell-type covariates included 
in the model. Similarly, to visualize the ability of this procedure to correct the batch 
effect present was first examined visually by performing a UMAP on the log counts. This 
plot is shown in figure 31 and 32 below.  
In UMAP space there seems to be a partial correction of the batch effect where 
the Jurkat cells are beginning to mix across batches. The mixing is, however, not perfect, 
and there still seems to be an appreciable batch effect.  
To further examine the ability of this procedure to correct the batch effect, the 
percent variance in log counts for each gene explained by cell-type and batch was 
calculated; this is shown below in figure 33. After correction with ComBat-Seq, there is a 
lower total portion of variance explained by the Batch+Cell type models; however, a 
greater total portion of the explained variance appears to be explained by cell-type as 





















Figure 33: Explained Variance by Batch After ComBat-Seq Correction 
 
 
ComBat-Cell-Seq Batch Correction 
After correction with the ComBat-Seq without any cell-type information included 
in the correction, the data were corrected with information regarding cell-type included in 
the analysis. Again, to visualize the ability of this procedure to correct the batch effect 
present was first examined visually by performing a UMAP on the log counts. Plots of 
the corrected data are shown in figures 34 and 35 below colored by batch and cell-type 
respectively. Visually, based on the UMAP plots, there seems to be a much better 
correction of the data. There is seemingly complete overlap of the previously problematic 
Jurkat cells. Interestingly, there is not a marked reduction in the percent explained 
variance attributed to batch; this can be seen in figure 36 below. A greater portion of the 








Figure 35: UMAP plot of ComBat-Cell-Seq corrected Log-counts of Data Colored 






Figure 36: Explained Variance by Batch after ComBat-Cell-Seq Correction 
 
ComBat-SVA-Seq Batch Correction 
 
The last ComBat-Seq based batch correction was that using the ComBat-SVA-
Seq procedure. The first step in this procedure is to compute the surrogate variables using 
surrogate variable analysis. These surrogate variables were computed to model the cell-
type variance. The only other known source of variance, besides cell type, is batch; as 
such, SVA was used to compute latent structure of the counts matrix which is not related 
to this unwanted batch variation. The relationship between the first 4 surrogate variables 
and cell type is shown in figure 37 below. 
After computation of the surrogate variables, a ComBat-Seq correction was 
performed including the surrogate variables as covariates in the correction. was known a-
priori that there are 2 cell-types present in this dataset; accordingly, only one surrogate 
variable was included as covariates to uniquely explain the variance attributable to cell 
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type. This is supported by evidence seen in figure 37 where the first 2 surrogate variables 
seem to be related to cell-type; linear combinations of these variables could conceivably 
define the cell type. 
This was visualized with UMAP dimensional reductions of the data; these are 
presented in figures 38 and 39 below. The batch correction with this procedure is not 
visually as good as that where the cell-type was explicitly known; however, it does 
appear to be marginally better at correction of the batch effect than the covariate free 
correction; this is especially evident in the lower right of the Jurkat group where there is 
visually more overlap of the groups than in the ComBat-Seq corrected data.  
The explained variance after correction appears to look more like that in the 
ComBat-Cell-Seq. There is not a large reduction in the overall explained variance as was 
seen in the cell-type naive model; however, as seen in ComBat-Cell-Seq, there is not a 
large reduction in the percent of variance explained by the batch variable. This can be 














Figure 37: Simulated Batch Effect Unbalanced Design Surrogate Variables 1-4 to 
Model Cell Type 
 
 













Figure 39: UMAP plot of ComBatSVA-Seq Corrected Log-counts of Data Colored 
by Cell Type 
 
 
Figure 40: Explained Variance by Batch after ComBat-SVA-seq correction 
 
 
Comparison of ComBat-Seq based Corrections 
 
Duplicated below are the UMAP plots of the log counts of both the uncorrected 
and the corrected data. Visually, it appears that all the correction procedures performed 
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on this data appropriately remove the unwanted variation related to batch. The correction 
method that most adequately removes the unwanted variation in the data is the ComBat-
Cell-Seq where there is little variation related to batch after correction. The other two 
ComBat-Seq based correction methods do remove some variance related to batch; 
however, there is still a slight batch effect present after both of these corrections.  
 












Comparison of ComBat-Seq based Results to Harmony 
 
As was done in the simulated data analysis, the results of the ComBat-Seq based 
methods were compared to those obtained from Harmony. Harmony batch correction was 
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performed with the following procedure: first, the principal components of the raw log 
counts matrix were computed. Next, the harmony procedure was employed to perform 
the batch correction on the first 20 principal components to yield corrected principal 
components. The corrected principal components were then used to perform a Harmony 
adjustment. A UMAP was performed using these corrected principal components; this is 
shown in the figure below.   
For both the uncorrected data and the ComBat-Seq based method corrected log 
counts matrices, the principal components were also computed. These were used to 
perform the same UMAP dimensional reduction as in the Harmony visualization. These 
are also all summarized in the figure below. The overlap between batches within a given 
cell type is clearly best with the Harmony correction with ComBat-Cell-Seq being the 
second-best method. In certain cases, this could be the correct choice of method; 
however, in the case where there is biological variance which is confounded by batch 
removal of the entire batch effect may be inappropriate. Further, in the case where a 










Figure 42: Comparison of ComBat-Seq Based Methods to Harmony Correction 
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 This work demonstrated that in both simulated and real data sets, ComBat-Seq 
batch correction methods are appropriate to reduce the unwanted variation in single cell 
RNA sequencing data. In the first simulated analysis, we demonstrated that in a 
somewhat balanced design either ComBat-Seq can be used with or without any cell-type 
information included in the batch correction. We further demonstrated that in unbalanced 
design, cell type can be included in the combat-seq correction to improve the accuracy of 
said correction. If cell type information is not known, we demonstrated that surrogate 
variable analysis can be used to model the variance attributable to cell type. It was further 
demonstrated that inclusion of surrogate variables that model cell-type does seem to 
improve the accuracy of the ComBat-Seq correction in unbalanced designs when the cell 
type is not known.  
The results obtained from the ComBat-Seq based corrections were compared to 
those obtained from the Harmony-based corrections. In both the balanced and unbalanced 
design there were clear differences between the ability of Harmony to correct the data 
and the ability of single cell ComBat-Seq to correct the data. The ComBat-Seq correction 
methods were able to appropriately correct the data, especially when the model was given 
cell type covariate information; whereas, Harmony was not able to appropriately correct 
this data.  
After analysis of the simulated data, we then looked at a real data set. The 
ComBat-Seq based methods were again able to remove the unwanted variation seen in 
the data. This was a heavily unbalanced design with certain cells entirely absent from one 
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batch or the other. ComBat-Seq, without any covariates, resulted in a slightly less 
prominent batch effect as visualized by UMAP; however, there is still certainly present in 
this correction. The same can be said for ComBat-SVA-Seq where there was again a 
reduction in the prominence of the batch effect; however, the batch effect was slightly 
less severe than in the ComBat-Seq corrected data. Finally, the ComBat-Cell-Seq 
corrected data was the best performing ComBat-Seq based method tested based on visual 
comparison of the UMAP plots.  
This analysis supports the procedure laid out in the method section. To reiterate, if 
cell-type information is known, this information should be used in the ComBat-Seq 
correction. If cell type information is not known, if the design is balanced, the cell type 
information can be omitted from the correction algorithm. If the cell-type is not balanced 
between the batches and if the design is thought to be unbalanced, one must determine 
the underlying latent variation related to cell-type with surrogate variable analysis.   
Inclusion of these latent variables to provide the combat algorithm with cell type 
information results in a more accurate batch correction. 
This algorithm and the result obtained from it were compared to Harmony batch 
correction. In the simulated balanced design, there were no clear advantages to one 
method over the other with the exception that the ComBat-Seq based methods return a 
counts matrix whereas the Harmony method does not. In looking at the unbalanced 
simulated data, there is a clear benefit to the combat-based corrections. Harmony was not 
able to appropriately correct the data whereas the methods propose here were. Lastly in 
looking at the real data set, Harmony visually seems too slightly outperform the ComBat-
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Cell-Seq method; however, given that ComBat-Cell returns accounts matrix this could be 
advantageous in certain scenarios. Lastly, ComBat-Seq preserves some biological 
variation within a cell-type across batches; there are certain cases where this is 
advantageous. Harmony appears to remove some of this information; it is possible that 
they are removing biologically relevant information. Further, given that harmony 
performs a correction on principle components, a visualization based on those corrected 
principle components is expected to appear better. The ComBat-Seq based corrections 
correct a far greater amount of data and therefore the slight loss in performance is not 
unexpected.  
This work demonstrated that ComBat-Seq can be adapted to be used for single 
cell RNA sequencing data. Future work could include performing the same analysis with 
other clustering methods, instead of surrogate variable analysis, to determine cell type. 
Additionally, future work could involve assessing the performance of the ComBat-SC-
Seq method with more rigorous measures of batch effect. Lastly, another future analysis 
could include down from analysis of corrected data to determine if the corrected data 
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